Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Beneficial effects of SUN-11031 in COPD patients with cachexia reported

Dec. 16, 2009

Studies find benefit with intravitreal dexamethasone implant in ocular indications

Dec. 16, 2009

Pharmacyclics presents phase I data on lymphoma agents

Dec. 16, 2009

Novel proteasome inhibitor NPI-0052 shows safety in phase I trials

Dec. 16, 2009

Tenecteplase restores function to occluded central venous catheters

Dec. 16, 2009

CALISTO trial reveals efficacy of fondaparinux in treating superficial vein thrombosis

Dec. 15, 2009

Phase I data reported for terameprocol in patients with advanced leukemias

Dec. 15, 2009

GMI-1070 shows safety and tolerability in phase I trial in healthy subjects

Dec. 15, 2009

Data from phase II and III trials support efficacy of prucalopride in chronic constipation

Dec. 15, 2009

Vitreosolve effective in clinical trials for PVD induction in diabetic retinopathy

Dec. 15, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...